English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objectives: Asthma is a heterogeneous disease with airway inflammation and has many phenotypes. There is a need for easily measurable biomarkers in the differentiation of phenotypes. Systemic immune-inflammation index (SII) has been studied in many malignancies and vasculitis as an important indicator of systemic inflammation and prognosis. The aim of this study is to test the usability of an easily calculated method like SII in the differentiation of asthma and NSAID-exacerbated respiratory disease (NERD).

Role of Systemic Immun-Inflamation Index in Asthma and NSAID Exacerbated Respiratory Disease